2024-09-03 - Analysis Report
## CVS Stock Analysis Report

**Company Overview:** CVS Health Corporation is a healthcare company that operates retail pharmacies, pharmacy benefit management (PBM) services, and healthcare services.

**1. Performance vs. S&P 500 (VOO):**

* **CVS Cumulative Return:** -17.37%
* **S&P 500 (VOO) Cumulative Return:** 89.66%
* **Performance Gap:** -107.03%
* **Relative Divergence:** 0.0 (meaning the current performance is at the lowest point compared to its historical range of divergence from the S&P 500).

**2. Recent Price Action:**

* **Closing Price:** 57.24
* **5-Day Moving Average:** 57.52
* **20-Day Moving Average:** 57.56
* **60-Day Moving Average:** 58.95

The price is currently below all moving averages, indicating a short-term downtrend.

**3. Technical Indicators:**

* **RSI:** 59.78 -  The RSI is in the neutral zone, suggesting neither overbought nor oversold conditions.
* **PPO:** -0.05 -  The PPO is negative, indicating a potential downtrend, though it is close to neutral.
* **Delta_Previous_Relative_Divergence:** -11.1 - This negative value indicates a recent decline in relative divergence.
* **Expected Return:** 12.6% - This figure represents the potential maximum 5-year return for a dollar-cost averaging investment strategy.

**4. Recent Earnings & Outlook:**

| Date | EPS | Expected EPS |
|---|---|---|
| 2024-08-07 | 1.83 | 1.73 |
| 2024-05-01 | 1.31 | 1.7 |
| 2024-02-07 | 2.12 | 2.01 |
| 2023-11-01 | 2.21 | 2.13 |
| 2023-08-02 | 2.21 | 2.12 |

The most recent earnings report (2024-08-07) showed that CVS beat expectations. However, previous quarters have shown mixed results, with some quarters exceeding expectations and others falling short. 

**5. Overall Analysis:**

CVS has significantly underperformed the S&P 500 over the long term. The stock is currently in a downtrend with technical indicators suggesting some weakness. While the most recent earnings beat expectations, historical earnings show volatility. The expected return, however, remains positive. 

**6. Conclusion:**

CVS stock is currently trading at a discount compared to its historical performance and the broader market. The recent earnings beat and a potentially positive expected return offer some hope for future growth. However, investors should be aware of the stock's recent downtrend and volatile earnings.  Further research into the company's future prospects, competitive landscape, and market trends is recommended before making any investment decisions. 
